Status:
COMPLETED
Home-based Intermittent Pneumatic Compression Therapy for Gynecologic Cancer
Lead Sponsor:
Samsung Medical Center
Collaborating Sponsors:
Ministry of Health, Republic of Korea
Conditions:
Gynecologic Cancer
Lymphedema of Leg
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Investigators conducted a prospective study of cancer patients to investigate the efficacy, quality of life, satisfaction, and safety of a home-based intermittent pneumatic compression (IPC) device du...
Eligibility Criteria
Inclusion
- stage 3 chronic unilateral secondary leg lymphedema
- aged 20-70 years
- underwent 1-2 cycle of treatment of decongestive phase with current inter-limb volume difference of more than 10%
- stable limb-volume change (within 10%) during the preceding 3 months
- capacity for self-maintenance care for lymphedema (multilayer limb bandaging, compression garments, and MLD)
Exclusion
- bilateral leg lymphedema
- current cancer metastasis
- ongoing chemotherapy or radiation therapy
- acute inflammation
- venous thrombosis, or chronic venous insufficiency
- systemic etiologies of edema
- congestive heart failure
- patients taking medication that influenced body fluid or electrolytes
Key Trial Info
Start Date :
March 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 3 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05193357
Start Date
March 7 2019
End Date
December 3 2019
Last Update
January 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea